Cleared Abbreviated

K013349 - ASTRONOMER PLUS SYSTEM

K013349 is an FDA 510(k) clearance for ASTRONOMER PLUS SYSTEM, manufactured by Ep Technologies, Inc.. The device is a Class 2 Cardiovascular device with product code DQK cleared through the Abbreviated 510(k) pathway after a 182-day FDA review.

K013349 · Ep Technologies, Inc. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Apr 2002
Decision
182d
Days
Class 2
Risk

K013349 is an FDA 510(k) clearance for the ASTRONOMER PLUS SYSTEM. Classified as Computer, Diagnostic, Programmable (product code DQK), Class II - Special Controls.

Submitted by Ep Technologies, Inc. (San Jose, US). The FDA issued a Cleared decision on April 9, 2002 after a review of 182 days - an extended review cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1425 - the FDA cardiovascular device oversight framework. The Abbreviated 510(k) pathway was used, relying on FDA-recognized standards to demonstrate substantial equivalence.

Device pattern: Standards-based predicate clearance. Standards-verified equivalence. The Abbreviated pathway signals strong alignment with FDA-recognized performance standards - typically associated with lower review burden and faster clearance cycles.

View all Ep Technologies, Inc. devices

FDA 510(k) Submission Details - K013349

510(k) Number K013349 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 09, 2001
Decision Date April 09, 2002
Days to Decision 182 days
Submission Type Abbreviated
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
57d slower than avg
Panel avg: 125d · This submission: 182d
Pathway characteristics
Standards-based clearance path.

DQK Device Classification - Class 2, Special Controls

Product Code DQK Computer, Diagnostic, Programmable
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1425
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DQK Computer, Diagnostic, Programmable

All 331
Devices cleared under the same product code (DQK) and FDA review panel - the closest regulatory comparables to K013349.
QUINTON Q-CATH, MODEL 000460
K021906 · Quinton, Inc. · Sep 2002
MAC-LAB/CARDIOLAB EP/COMBOLAB
K021366 · General Electric Medical Systems Information Techn · Jul 2002
PHYSIOLOG, SERIES 95000
K013032 · Camtronics, Ltd. · Jun 2002
MAC 5000 ECG ANALYSIS SYSTEM
K014108 · General Electric Medical Systems Information Techn · Jan 2002
CARTO XP EP NAVIGATION SYSTEM
K013083 · Biosense Webster, Inc. · Nov 2001
ALTERNANAS PROCESSING SYSTEM, CH 2000 CARDIAC DIAGNOSTIC SYSTEM, HEARTWAVE ALTERNANS PROCESSING SYSTEM
K012206 · Cambridge Heart, Inc. · Oct 2001